Video

Dr. Markman Discusses Diagnostic Molecular Testing

Dr. Maurie Markman from Cancer Treatment Centers of America Discusses Diagnostic Molecular Testing

Maurie Markman, MD, senior vice president for Clinical Affairs, National Director for Medical Oncology, Cancer Treatment Centers of America, Eastern Regional Medical Center, explains the shift in diagnostic tools towards molecular testing.

Cancer treatment is moving towards a molecular diagnostic paradigm. Various forms of diagnostic testing have been used for quite some time but only recently the type of testing has become more molecularly based. Very detailed molecular profiles of each individual's cancer can help determine a cure, spread of the disease, and the efficacy of therapy.

Markman believes that molecular diagnostics are revolutionary and will bring about more changes in cancer care than the past 100 years of cancer management advances.

Related Videos
Sheldon M. Feldman, MD
Rita Mukhtar, MD
Lajos Pusztai, MD, DPhil
Hope S. Rugo, MD
Marc Machaalani, MD
Craig Eckfeldt, MD, PhD, assistant professor, medicine, faculty, Microbiology, Immunology, and Cancer Biology PhD Graduate Program, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
Alicia Morgans, MD, MPH, genitourinary medical oncologist, medical director, Survivorship Program, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Alfred L. Garfall, MD, MS
Razane El Hajj Chehade, MD
Mark Juckett, MD, professor, medicine, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School